Zawadzki v. Knight
Opinion of the Court
— Order modified on the law and as modified affirmed without costs, in accordance with the following memorandum: Plaintiff commenced this action against
We do not review the denial of Biozyme’s motion to dismiss the cross claims against it, as the cross claims are not in the record on appeal, and the parties making the cross claims are not involved in this appeal.
All concur, except Callahan, J. P., and Balio, J., who dissent and vote to affirm in the following memorandum.
Dissenting Opinion
(dissenting). We dissent. In our view, Supreme Court properly denied summary judgment and we should affirm. It is well recognized that summary judgment is a drastic remedy and is rarely granted in negligence actions (Ugarriza v Schmieder, 46 NY2d 471, 474). A defendant seeking summary judgment must present evidence establishing that plaintiff has no cause of action (Hayes v Riccardi, 97 AD2d 954) and that no material and triable issue of fact is presented by the pleadings (Walski v Forma, 54 AD2d 776).
A review of the record clearly shows that there are triable questions of fact that preclude awarding defendant summary judgment. Even assuming that Biozyme has met its initial burden of showing entitlement to summary judgment, plaintiff has met his burden by submitting proof from his medical expert which demonstrates the viability of the theory hypothesized by the plaintiff. We must be ever mindful that in ruling on a summary judgment motion, the court may not assess credibility or weigh conflicting affidavits.
Our role is issue finding, not issue resolution. Summary relief should be denied where there is any doubt, as here, regarding the existence of a factual issue (see, Manufacturers & Traders Trust Co. v Cottrell, 71 AD2d 538; Bracie v Yeshiva Univ., 88 AD2d 823). Since the plaintiff, as the nonmoving
Case-law data current through December 31, 2025. Source: CourtListener bulk data.